Discover 208 paid clinical trials in Bellingham, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 208
Active & Responsive
A Study of Brenipatide in Adult Participants With Major Depressive Disorder
for
Depressive Disorder, Major
Location: Richmond, Bellevue WA, Portland OR, Clinton UT,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07412756
Phase 3, Recruiting
Active & Responsive
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
for
HIV Infections
Location: Vancouver, Seattle WA, Salt Lake City UT, Regina,
Sponsor: ViiV Healthcare
Sex: All
Age: 12+
Code: NCT07650916
Phase 3, Recruiting
Active & Responsive
Advancing Transplantation Outcomes in Children
for
Kidney Transplant
Location: Vancouver, Seattle WA, Los Angeles CA, Aurora CO,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All
Age: 13 - 20
Code: NCT06055608
Phase 2, Recruiting
Active & Responsive
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
for
Type 1 Diabetes Mellitus With Hypoglycemia
Location: Vancouver, Seattle WA, Calgary, Sandy City UT,
Sponsor: Zucara Therapeutics Inc.
Sex: All
Age: 18 - 70+
Code: NCT05762107
Phase 2, Recruiting
Active & Responsive
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Vancouver, Edmonds WA, Seattle WA, Vancouver WA,
Sponsor: Bicara Therapeutics
Sex: All
Age: 18+
Code: NCT06788990
Phase 2, Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)
for
Advanced Melanoma
Location: Vancouver, Seattle WA, Salt Lake City UT, Phoenix AZ,
Sponsor: Immunocore Ltd
Sex: All
Age: 18+
Code: NCT05549297
Phase 3, Recruiting
Active & Responsive
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity